Vical develops biopharmaceutical products for the prevention and treatment of chronic or life-threatening infectious diseases, based on our patented DNA delivery technologies and other therapeutic approaches.

RECENT NEWS

September 6, 2017 Vical to Present at the Rodman & Renshaw 19th Annual Global Investment Conference
August 8, 2017 Vical Reports Second Quarter 2017 Financial and Operational Results

September 6, 2017
Vical to Present at the Rodman & Renshaw 19th Annual Global Investment Conference

August 8, 2017
Vical Reports Second Quarter 2017 Financial and Operational Results

EVENTS & PRESENTATIONS

September 12, 2017 Rodman & Renshaw 19th Annual Global Investment Conference View the Webcast
August 8, 2017 Vical Inc. 2Q17 Financial Results Conference Call View the Webcast

September 12, 2017
Rodman & Renshaw 19th Annual Global Investment Conference

August 8, 2017
Vical Inc. 2Q17 Financial Results Conference Call

PRODUCT PIPELINE

CONNECT WITH US

RSS Feeds
Email Alerts
LinkedIn
Slideshare
StockTwits
Twitter
YouTube

Privacy Policy
Terms of Use
Site Map

P. 858 646 1100 10390 Pacific Center Court, San Diego, California 92121

This link to a non-Vical website is provided as a resource. Vical assumes no responsibility for content not provided by Vical, or for practices or standards of any non-Vical websites.